F

Fluoguide AS
STO:FLUO

Watchlist Manager
Fluoguide AS
STO:FLUO
Watchlist
Price: 35.2 SEK
Market Cap: 479.4m SEK
Have any thoughts about
Fluoguide AS?
Write Note

Fluoguide AS
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fluoguide AS
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluoguide AS
STO:FLUO
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Revenue
kr19B
CAGR 3-Years
37%
CAGR 5-Years
43%
CAGR 10-Years
39%
Zealand Pharma A/S
CSE:ZEAL
Revenue
kr76.9m
CAGR 3-Years
-22%
CAGR 5-Years
12%
CAGR 10-Years
-7%
Ascendis Pharma A/S
NASDAQ:ASND
Revenue
€327.4m
CAGR 3-Years
357%
CAGR 5-Years
73%
CAGR 10-Years
35%
B
Bavarian Nordic A/S
CSE:BAVA
Revenue
kr6.1B
CAGR 3-Years
53%
CAGR 5-Years
57%
CAGR 10-Years
19%
Bioporto A/S
CSE:BIOPOR
Revenue
kr33.8m
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
6%
No Stocks Found

Fluoguide AS
Glance View

Market Cap
436.8m SEK
Industry
Biotechnology

FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.

FLUO Intrinsic Value
38.97 SEK
Undervaluation 10%
Intrinsic Value
Price
F

See Also

What is Fluoguide AS's Revenue?
Revenue
0 DKK

Based on the financial report for Dec 31, 2023, Fluoguide AS's Revenue amounts to 0 DKK.

Back to Top